Search results

Saughter and May advised Standard Chartered PLC on its issuance of US$2 billion Senior Notes Saughter and May advised Standard Chartered in relation to its strategic investment in Linklogis, China’s leading supply chain financing platform Saughter and May is advising Bertelsmann on its $675m acquisition of the remaining 25% stake in Penguin Random House Saughter and May advises ISS on liability management exercise Saughter and May advises ISS on liability management exercise Saughter and May is advising IWG plc on its strategic partnership and franchising arrangements with J. Safra Group and the Peress Group Saughter and May is advising IWG plc (“IWG”), the global operator of leading co-work and workspace brands, on a strategic partnership with an entity jointly owned by J. Safra Group and the Peress Group (the “Purchaser”). Saughter and May is advising CLSA Capital Markets on the privatisation of Huaneng Renewables Corporation Saughter and May advised Derwent London as first UK REIT to sign green revolving credit facility Saughter and May is advising on the administration of QuickQuid / CashEuroNet, UK LLC Saughter and May is advising on the administration of QuickQuid / CashEuroNet, UK LLC Saughter and May advises Goldman Sachs on the HK$ 6.7 billion top-up placing by China Resources Land Saughter and May advised Just Group plc on its debt issuance of Tier 2 capital and tender offer Saughter and May advised Just Group plc on its issuance of Tier 2 capital and tender offer in respect of Partnership Life Assurance Company Limited £100,000,000 9.5% fixed rate subordinated notes (“PLACL Notes”). Saughter and May advised Thermo Fisher Scientific on its agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline plc Saughter and May advised Thermo Fisher Scientific on its agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline plc for approximately €90 million in cash.